208 related articles for article (PubMed ID: 9464999)
1. Turnover of amyloid beta-protein in mouse brain and acute reduction of its level by phorbol ester.
Savage MJ; Trusko SP; Howland DS; Pinsker LR; Mistretta S; Reaume AG; Greenberg BD; Siman R; Scott RW
J Neurosci; 1998 Mar; 18(5):1743-52. PubMed ID: 9464999
[TBL] [Abstract][Full Text] [Related]
2. Protein kinase C epsilon suppresses Abeta production and promotes activation of alpha-secretase.
Zhu G; Wang D; Lin YH; McMahon T; Koo EH; Messing RO
Biochem Biophys Res Commun; 2001 Jul; 285(4):997-1006. PubMed ID: 11467851
[TBL] [Abstract][Full Text] [Related]
3. Dynamics of Abeta turnover and deposition in different beta-amyloid precursor protein transgenic mouse models following gamma-secretase inhibition.
Abramowski D; Wiederhold KH; Furrer U; Jaton AL; Neuenschwander A; Runser MJ; Danner S; Reichwald J; Ammaturo D; Staab D; Stoeckli M; Rueeger H; Neumann U; Staufenbiel M
J Pharmacol Exp Ther; 2008 Nov; 327(2):411-24. PubMed ID: 18687920
[TBL] [Abstract][Full Text] [Related]
4. Presenilin 1 regulates the processing of beta-amyloid precursor protein C-terminal fragments and the generation of amyloid beta-protein in endoplasmic reticulum and Golgi.
Xia W; Zhang J; Ostaszewski BL; Kimberly WT; Seubert P; Koo EH; Shen J; Selkoe DJ
Biochemistry; 1998 Nov; 37(47):16465-71. PubMed ID: 9843412
[TBL] [Abstract][Full Text] [Related]
5. Huperzine A regulates amyloid precursor protein processing via protein kinase C and mitogen-activated protein kinase pathways in neuroblastoma SK-N-SH cells over-expressing wild type human amyloid precursor protein 695.
Peng Y; Lee DY; Jiang L; Ma Z; Schachter SC; Lemere CA
Neuroscience; 2007 Dec; 150(2):386-95. PubMed ID: 17945434
[TBL] [Abstract][Full Text] [Related]
6. Dual-specificity phosphatase 26 (DUSP26) stimulates Aβ42 generation by promoting amyloid precursor protein axonal transport during hypoxia.
Jung S; Nah J; Han J; Choi SG; Kim H; Park J; Pyo HK; Jung YK
J Neurochem; 2016 Jun; 137(5):770-81. PubMed ID: 26924229
[TBL] [Abstract][Full Text] [Related]
7. The A673T mutation in the amyloid precursor protein reduces the production of β-amyloid protein from its β-carboxyl terminal fragment in cells.
Kokawa A; Ishihara S; Fujiwara H; Nobuhara M; Iwata M; Ihara Y; Funamoto S
Acta Neuropathol Commun; 2015 Nov; 3():66. PubMed ID: 26531305
[TBL] [Abstract][Full Text] [Related]
8. Additive effects of basic fibroblast growth factor and phorbol ester on beta-amyloid precursor protein expression and secretion.
Ringheim GE; Aschmies S; Petko W
Neurochem Int; 1997; 30(4-5):475-81. PubMed ID: 9106263
[TBL] [Abstract][Full Text] [Related]
9. Auraptene increases the production of amyloid-β via c-Jun N-terminal kinase-dependent activation of γ-secretase.
Jung CG; Uhm KO; Horike H; Kim MJ; Misumi S; Ishida A; Ueda Y; Choi EK; Kim YS; Michikawa M; Hida H
J Alzheimers Dis; 2015; 43(4):1215-28. PubMed ID: 25147119
[TBL] [Abstract][Full Text] [Related]
10. A novel approach for studying endogenous abeta processing using cultured primary neurons isolated from APP transgenic mice.
Qiu Z; Naten DL; Liston JC; Yess J; Rebeck GW
Exp Neurol; 2001 Jul; 170(1):186-94. PubMed ID: 11421596
[TBL] [Abstract][Full Text] [Related]
11. Mutagenesis identifies new signals for beta-amyloid precursor protein endocytosis, turnover, and the generation of secreted fragments, including Abeta42.
Perez RG; Soriano S; Hayes JD; Ostaszewski B; Xia W; Selkoe DJ; Chen X; Stokin GB; Koo EH
J Biol Chem; 1999 Jul; 274(27):18851-6. PubMed ID: 10383380
[TBL] [Abstract][Full Text] [Related]
12. Protein kinase C activation increases release of secreted amyloid precursor protein without decreasing Abeta production in human primary neuron cultures.
LeBlanc AC; Koutroumanis M; Goodyer CG
J Neurosci; 1998 Apr; 18(8):2907-13. PubMed ID: 9526007
[TBL] [Abstract][Full Text] [Related]
13. Beta-amyloid peptide in regulated secretory vesicles of chromaffin cells: evidence for multiple cysteine proteolytic activities in distinct pathways for beta-secretase activity in chromaffin vesicles.
Hook VY; Toneff T; Aaron W; Yasothornsrikul S; Bundey R; Reisine T
J Neurochem; 2002 Apr; 81(2):237-56. PubMed ID: 12064471
[TBL] [Abstract][Full Text] [Related]
14. Control of BACE1 degradation and APP processing by ubiquitin carboxyl-terminal hydrolase L1.
Zhang M; Deng Y; Luo Y; Zhang S; Zou H; Cai F; Wada K; Song W
J Neurochem; 2012 Mar; 120(6):1129-38. PubMed ID: 22212137
[TBL] [Abstract][Full Text] [Related]
15. Prion-like propagation of β-amyloid aggregates in the absence of APP overexpression.
Ruiz-Riquelme A; Lau HHC; Stuart E; Goczi AN; Wang Z; Schmitt-Ulms G; Watts JC
Acta Neuropathol Commun; 2018 Apr; 6(1):26. PubMed ID: 29615128
[TBL] [Abstract][Full Text] [Related]
16. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
[TBL] [Abstract][Full Text] [Related]
17. In vivo assessment of brain interstitial fluid with microdialysis reveals plaque-associated changes in amyloid-beta metabolism and half-life.
Cirrito JR; May PC; O'Dell MA; Taylor JW; Parsadanian M; Cramer JW; Audia JE; Nissen JS; Bales KR; Paul SM; DeMattos RB; Holtzman DM
J Neurosci; 2003 Oct; 23(26):8844-53. PubMed ID: 14523085
[TBL] [Abstract][Full Text] [Related]
18. Conversion of Aβ43 to Aβ40 by the successive action of angiotensin-converting enzyme 2 and angiotensin-converting enzyme.
Liu S; Liu J; Miura Y; Tanabe C; Maeda T; Terayama Y; Turner AJ; Zou K; Komano H
J Neurosci Res; 2014 Sep; 92(9):1178-86. PubMed ID: 24823497
[TBL] [Abstract][Full Text] [Related]
19. Promising multifunctional anti-Alzheimer's dimer bis(7)-Cognitin acting as an activator of protein kinase C regulates activities of alpha-secretase and BACE-1 concurrently.
Fu H; Dou J; Li W; Cui W; Mak S; Hu Q; Luo J; Lam CS; Pang Y; Youdim MB; Han Y
Eur J Pharmacol; 2009 Nov; 623(1-3):14-21. PubMed ID: 19765582
[TBL] [Abstract][Full Text] [Related]
20. Oral administration of a potent and selective non-peptidic BACE-1 inhibitor decreases beta-cleavage of amyloid precursor protein and amyloid-beta production in vivo.
Hussain I; Hawkins J; Harrison D; Hille C; Wayne G; Cutler L; Buck T; Walter D; Demont E; Howes C; Naylor A; Jeffrey P; Gonzalez MI; Dingwall C; Michel A; Redshaw S; Davis JB
J Neurochem; 2007 Feb; 100(3):802-9. PubMed ID: 17156133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]